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very	 important	 signaling	 molecules	 for	 bacterial	 growth	 and	 human	 innate	 immune	 system	













































Diazo	 compounds	 are	 versatile	 building	 blocks	 and	 used	 prevalently	 in	 synthetic	 chemistry	 and	
chemical	 biology.1,	 2	 Ethyl	 diazoacetate	 (EDA)	 was	 the	 first	 synthetic	 diazo	 compound	 which	 was	
preapred	by	Curtius	in	1883.3	The	structure	of	the	diazo	group	was	confirmed	to	be	in	a	linear	form	by	
isotopic	 labeled	 experiment	 (Scheme	1.1).4	 The	 terminal	 15N	 labeled	 EDA	was	 obtained	 from	ethyl	
glycinate	 diazotisition.	 After	 hydrogenation	 of	 the	 labeled	 diazo	 compound,	 the	 terminal	 15N	 was	












negative	 charge	 can	 be	 further	 delocalized	 to	 the	 substituted	 group	 such	 as	 aromatic,	 carbonyl,	
phosphoryl,	 and	 sulfonyl	 substituents.	 Thus	 the	 stabilized	 ones	 are	 more	 likely	 existing	 in	 the	








































The	 release	 of	 nitrogen	 gas	 is	 the	 driving	 force	 for	 the	 decomposition	 of	 diazo	 compounds.	 Acidic	
conditions	favor	the	thermodynamic	stable	nitrogen	formation	by	adding	a	proton	to	the	nucleophilic	
carbon	of	 the	diazo	 compound.	The	 instability	of	diazo	 compounds	 toward	acids	also	models	 their	
reactivity	with	Lewis	acidic	transition	metal	catalysts.	The	transition-metal-catalyzed	transformations	
of	diazo	compounds	to	stabilized	carbenoids	are	ubiquitous	in	diazo	chemistry.6-9	The	metal-carbenoid	
intermediates	 are	 capable	 of	 undergoing	 a	 range	 of	 reactions	 with	 high	 chemo-,	 regio-,	 and	








































Rh2(OAc)4	 was	 first	 used	 by	 Teyssie	 in	 1973	 to	 decompose	 EDA	 to	 produce	 a	 rhodium–carbenoid	
intermediate,	 subsequent	O–H	 insertion	 then	delivered	ethers.16	 Later	 they	 reported	 that	 rhodium	
carboxylates	were	also	efficient	catalysts	for	N–H	and	S–H	insertion.	These	seminal	observations	set	
the	stage	for	forty	years	of	intensive	study	with	rhodium	(II)	catalysts.	As	a	result	the	substrate	scope	
has	 been	widely	 expanded	 to	 include	 aliphatic	 amine,	 aniline,	 amide,	 alcohols,	 phenols,	 thiols	 and	
silanes.	The	discovery	of	the	incredible	catalytic	abilities	of	rhodium	(II)	acetate	leads	the	attention	to	
creating	 asymmetric	 catalysts	 based	 on	 rhodium	 (II).	 Over	 the	 ensuing	 years,	 the	 development	 of	








EDA	 into	 N–H	 bonds	 of	 amines	 and	 amides	 in	 high	 yields	 under	mild	 conditions.19	 The	 electronic	
interaction	between	the	copper	and	the	heterocyclic	 ligand	not	only	enhanced	its	stability,	but	also	
improved	its	reactivity	and	selectivity	in	the	XHI	reaction	as	a	result	of	its	unique	structure.		Especially	









rhodium(II)-catalyzed	 reaction	 paths	 (Scheme	 1.7).20	 They	 found	 that	 a	 crucial	 difference	 in	 the	














received	 by	 potential	 users.	 The	Woo	 and	 Gross	 groups	 have	 independently	 shown	 that	 iron(III)–
corrole	and	 iron(III)–porphyrin	complexes	are	excellent	catalysts	 for	N–H	 insertion	 into	a	variety	of	
amines	 and	 diazo	 substrates.23,	 24	 Furthermore,	 the	 recent	 application	 of	 iron–spirobisoxaline	

















H	 insertion30	 reactions,	 reported	 by	 the	 Che	 and	 Lacour	 groups	 respectively,	 demonstrate	 that	

































simultaneously	 that	 the	active-site	carboxyl	 residue	of	pepsin	 is	modified	with	diazo	compounds	at	
least	103	 fold	 faster	 in	 the	presence	of	 large	excesses	of	copper(II)	 salts.	Although	the	mechanistic	
underpinnings	 of	 the	 reaction	 were	 unknown	 at	 the	 time,	 such	 reactivity	 with	 carboxylates	 is	









in	 myoglobin	 and	 subtilisin	 could	 be	 modified	 at	 low	 pH	 using	 α-diazo	 esters	 and	 dirhodium	
tetraacetate	 (see	 Scheme	 1.9).34	 The	 reaction	 seems	 to	 proceed	 by	 a	 mixture	 of	 XHI	 and	










a	 rhodium–carbenoid	 intermediate	 to	 specific	 amino	 acids	 were	 achieved	 by	 the	 combination	 of	





While	 customized	 nucleic	 acids	 could	 be	 obtained	 by	 oligonucleotide	 solid	 support	 synthesis,	
comprehensive	laborious	work	is	needed.	Our	group	recently	reported	that	rhodium-carbenoids	can	





acids	 are	 conceivable,	 only	 N–H	 insertions	 into	 exocyclic	 amines	 of	 nucleobases	 were	 observed;	






























exposure	 limit	 is	 0.2	ppm	due	 to	 its	 high	 toxicity.	Diazomethane	generated	 in	 situ	 from	N-nitroso-
derivatives	 by	 base-promoted	 decomposition	 can	 be	 managed	 at	 a	 safe	 level.38	 Recently,	 the	
developments	of	flow	systems	combined	with	micro-reactor	technology	to	generate	diazomethane	in	
situ	 inside	 the	 reactor,	 greatly	 diminishing	 the	 chances	 of	 accidents.38,	 39	 On	 the	 other	 hand,	
trimethylsilyl	diazomethane	 is	more	 thermally	 stable	and	 less	explosive,	used	 frequently	 in	organic	
synthesis	as	a	safer,	commercially	available	alternative	to	diazomethane.	However,	precaution	to	its	
toxicity	should	be	raised	after	two	fatal	incidents.40		
Despite	 these	 safety	 concerns,	 alkyl	 diazo	 compounds	 are	 very	 useful	 precursors	 in	 synthetic	




forming	 the	 unstable	 diazocarbonoid	 to	 be	 attacked	 by	 nucleophiles.	 The	 equilibrium	 favoring	 the	
carbocation	(and	thus	the	rate	of	subsequent	reactions)	is	determined	by	the	strength	of	the	BrØnsted	
acid	and	the	stability	of	the	carbocation	produced	(Scheme	1.11).	Carbocations	generated	from	alkyl	





In	 stabilized	 diazo	 compounds,	 the	 carbon	 adjacent	 to	 the	 nitrogen	 group	 is	 weakly	 basic.	 The	
































Alkyl	 diazo	 compounds	 are	 potent	 alkylating	 reagents.	 They	 modify	 DNA	 at	 many	 different	 sites,	
thereby	producing	lethal	and	mutagenic	lesions	(Scheme	1.13).	The	alkylation	only	occurs	at	different	
sites	of	bases,	including	exocyclic	oxygens	and	most	ring	nitrogens,	but	also	happens	to	phosphates	of	
the	 DNA	 backbone,	 thereby	 generating	 phosphotriesters	 (Scheme	 1.13	 lower,	 modification	 site	 is	






Alkylation	 of	 the	 phosphate	 group	 of	 nucleic	 acids	 with	 aryl	 diazo	 compounds	 has	 a	 long	 history.	





















solvents	 to	 achieve	 phosphotriesters.	 Among	 them,	 coumarine	 diazo49	 and	 2-nitro-phenyl	 diazo	
methane50,	51	modified	nucleic	acids	are	capable	to	release	the	native	nucleic	acid	by	photolysis,	thus	
these	are	widely	used	as	nucleic	acid	caging	agents.	6-Bromo-4-diazomethyl-7-hydroxycoumarin	(Bhc-
diazo)	has	been	employed	 to	 react	with	 the	phosphate	moiety	of	 the	backbone	of	RNA,	modifying	
approximately	30	sites	on	the	phosphate	moieties	per	1	kb	of	RNA	sequence.52	The	Bhc-caged	green	
fluorescent	 protein	 (GFP)	 mRNA	 has	 severely	 reduced	 translational	 activity	 in	 vitro,	 whereas	
illumination	of	Bhc-caged	mRNA	with	ultraviolet	light	leads	to	partial	recovery	of	translational	activity.	
In	 embryos	 injected	with	 Bhc-caged	GFP	mRNA	 at	 the	 one-cell	 stage,	 GFP	 protein	 expression	 and	
fluorescence	 is	specifically	 induced	by	ultraviolet	 light.	However,	Friedman’s	 lab	demonstrated	that	

























































































second	 messengers	 in	 response	 to	 environmental	 changes.	 Bis-(3'-5')-cyclic	 dimeric	 guanosine	
monophosphate	(c-di-GMP)	is	a	ubiquitous	signaling	molecule	in	bacteria.55	Fluctuating	levels	of	c-di-
GMP	controls	their	lifestyle,	from	a	swarming	motile	phase	to	sessile	biofilm	formation,	which	is	an	
essential	 step	 for	 virulence	 and	 pathogenesis.56	 A	 c-di-GMP	 analog,	 c-di-AMP,	 is	 involved	 in	 the	
regulation	 of	 bacterial	 cell	 wall	 metabolism,	 osmotic	 stress	 responses	 and	 in	 pathogen-host	
interaction.57-59	C-di-GAMP	as	is	the	newest	member	of	second	messengers,	its	biological	role	is	still	
unknown.60	 Understanding	 how	 bacteria	 thrive	 and	 spread	 their	 population	 is	 important	 for	
environmental	protection	and	human	health.	Once	mammalian	cells	have	been	infected	by	bacteria,	
these	exogenous	3’,	5’-linked	CDNs	will	be	recognized	by	STING	of	the	host’s	innate	immune	system,	





in	 bacterial	 pathogens.	 The	 large	 scale	 overuse	 of	 antibiotics	 in	 livestock	 farming	 and	 fish	 farming	
becomes	 a	 big	 issue	 and	 alternative	 strategies	 are	 in	 urgent	 need	 instead	 of	 developing	 stronger	
antibiotics.		
Until	recently	CDNs	were	not	thought	to	be	produced	by	mammalian	cells	and	should	appear	in	the	
cytosol	 only	 because	 of	 the	 presence	 of	 invading	 bacteria.65	 Only	 very	 recently	 was	 c-di-GAMP	
discovered	in	mammalian	cell	in	an	unusual	isomeric	form	of	previous	CDNs.66,	67	This	unique	secondary	
messenger	 c-G(2',5')pA(3',5')p	 is	 produced	 endogenously,	 as	 the	 result	 of	 an	 mammalian	 innate	
immune	 response	 to	 pathogen-derived	 cytoplasmic	 double	 stranded	 DNA	 (dsDNA).67,	 68	 The	 c-

















recently.73	 Increasing	 levels	 of	 c-di-GMP	 lead	 to	 biofilm	 formation	 by	 enhancing	 the	 synthesis	 of	
adhesive	 structures	and	biofilm	matrix	 components.	While	decreasing	 levels	of	 c-di-GMP	stimulate	
dispersal	 of	 biofilms	 and	 promotes	 a	 planktonic	 lifestyle.	 Fluctuating	 levels	 of	 c-di-GMP	 initiate	
adaptive	 responses	 in	bacterial	 cells	when	 they	are	exposed	 to	various	 sources	of	 stress,	 including	
antibiotics,	 nutrient	 limitation,	 anaerobiosis,	 heat	 shock.	 The	 c-di-GMP	 signaling	 is	 not	 only	 at	 the	
transcriptional	 level	 by	 binding	 specific	 regulator	 protein	 or	 riboswitches,	 but	 also	 at	 a	 post-
translational	level	via	PilZ	domain	containing	proteins.	C-di-GMP	binds	to	its	effector	components	and	













At	 the	same	 time,	Sauer’s	group	demonstrated	elevated	 level	of	 c-di-GMP	 in	 the	planktonic	cell	of	
Pseudomonas	 aeruginosa	 benefits	 the	 brIR	 expression	 (brIR	 is	 a	 c-di-GMP	 responsive	 transcription	
regulator).	The	downstream	response	will	increase	the	survival	rate	against	antimicrobial	agents.78,	79	
Nevertheless,	 understanding	 the	 increased	 antibiotics	 tolerance	 is	 very	 important	 for	 bacterial	

































Like	 c-di-GMP,	 c-di-AMP	 is	 synthesized	 from	 ATP	 by	 DAC	 enzymes	 and	 is	 hydrolyzed	 by	
phosphodiesterase	(PDE)	enzymes.	Recently,	several	c-di-AMP	receptors	were	identified	to	be	involved	















di-AMP	 and	 operated	 upstream	 of	 STING.89	 STING’s	 recognition	 of	 CDNs	 as	 the	 danger	 signal	 and	
stimulation	 of	 immune	 response	 against	 bacterial	 infection	 suggested	 that	 CDNs	 could	 be	 used	 as	
22	
	
































production	of	 2’-3’	 c-di-GAMP	 is	 stimulated	 after	 detection	of	 pathogens’	 dsDNA	 leading	 to	 STING	
activation	(Figure	2.6).	The	exogenous	or	endogenous	CDNs	interacting	with	STING	study	provides	a	















Levels	 of	 CDNs	 are	 regulated	 by	 synthases	 and	 phosphodiesterases	 in	 biological	 conditions.	
Phosphorothioate	was	introduced	to	prevent	enzymatic	hydrolysis	because	this	artificial	linkage	can	
not	be	recognized	by	phosphodiesterases.	The	thioester	derivatives	have	similar	binding	affinities	to	








focused	on	making	changes	 to	 the	phosphate	 linkage	or	2’	position	of	 the	 ribose.96	For	example,	a	
propargyl	group	was	introduced	at	2’	position	of	the	phosphoramidite	before	the	total	synthesis.	The	













in	 all	 types	 of	 natural	 3’-5’-linked	 CDNs	 utilizing	 catalytic	 rhodium-based	 carbene	 transfer	 will	 be	











stacking	 and	G-quartet	 interactions.99,	 100	When	 the	 c-di-GMP	 concentration	was	 reduced	 to	 2mM,	
within	 20min,	 58%	 of	 c-di-GMP	 was	 converted	 to	 the	 desired	 product.	 After	 preparative	 HPLC	
purification,	39%	isolated	yield	was	obtained	(see	also	in	Table	2.1,	entry	4).	The	modified	position	was	









diazo	 starting	material	 (hence	 10	 equivalents	 are	 required);	 in	 some	 cases	minor	 double-modified	
products	 are	 also	 observed	 (0-18%).	 As	 shown	 in	 Table	 2.1	 the	 conversions	 range	 from	 33-80%	
depending	upon	the	precise	substrate	and	diazo	compound.	The	reactions	are	fast,	requiring	at	most	










	 	 	 	 	 	












































G	 alkylation	 according	 to	 integration	 of	 HPLC).	 The	 structures	 of	 the	 products	 were	 gleaned	
independently	from	NMR	(ROESY,	HMQC,	and	HMBC,	see	the	experimental	part	for	details)	and	MS–
MS	 fragmentation	 (Figure	 2.7).	With	 the	 sample	 from	 entry	 3	 in	 Table	 2.1,	 the	major	mass	 peaks	
matched	the	guanine-modified	structure	(see	panel	A,	Figure	2.7).	In	contrast,	the	minor	product	from	







challenge	 in	 chemoselectivity	 since	 adenine	 and	 guanine	 display	 similar	 functional	 groups	 to	 the	
catalyst.	However,	as	entries	3	and	5	demonstrate,	the	substrate	can	play	a	role	in	controlling	the	site-
selectivity.	The	source	of	the	change	could	be	related	to	the	charge	of	the	dimethylamino	group,	or	
the	 propensity	 of	 certain	 CDNs	 to	 form	higher-order	 aggregates	 in	 solution.	 Although	 the	 product	
mixture	 obtained	 from	 entry	 3	 of	 Table	 2.1	 was	 more	 complex,	 we	 were	 able	 to	 separate	 each	
component	(the	39%	reported	yield	corresponds	to	the	mixture)	and	therefore	c-GAMP	derivatives	are	
available	with	alterations	at	either	base	through	one	protocol.	
In	 prokaryotes	 CDNs	 are	 involved	 in	 a	 complicated	 regulatory	 network	 involving	 a	 multitude	 of	
individual	protein	components	and	several	riboswitches.	The	modified	CDN	derivatives	shown	in	Table	









































could	be	used	 to	modulate	 their	 function	or	 introduce	useful	 side-chains	 such	as	 fluorophores	and	






















unrealized	 potential	 for	 catalytic	 Cu(I)-carbenoid	 chemistry	 in	 water.101	 Combined	 with	 recently	
development	 of	 Cu(I)-carbenoids	 with	 diazo	 compounds	 in	 XHI	 reactions,	 it	 could	 offer	 another	
possibility	for	introducing	unnatural	chemical	motifs	into	native	nucleic	acid.	Additionally	the	Cu(I)	is	
also	a	well-known	catalyst	in	click	reaction	which	enable	the	efficient	and	straight-forward	introduction	








with	 the	CuAAC	conditions	 for	bioconjugation	developed	by	Finn.	The	key	components	of	 the	Finn	
conditions	are	sodium	ascorbate	and	the	tris(3-hydroxypropyltriazolyl-	methyl)amine	(THPTA)	ligand.	





























Based	 on	 the	 fact	 that	 our	 NHI	 process	 is	 fully	 compatible	 with	 the	 Cu-catalyzed	 azide–alkyne	
cycloaddition	 (CuAAC),	 therefore	 we	 attempted	 to	 investigate	 the	 possibility	 of	 a	 simultaneous	
CuAAC/NHI	 process.	 The	 concept	 was	 tested	 with	 a	 collection	 of	 different	 amines,	 alkynes,	 diazo	
compounds,	and	azides	as	shown	in	Table	2.3.	Our	initial	experiments	with	small	molecule	substrates	
and	in	all	cases	the	N-aryl	triazole/NHI	products	were	obtained	in	good	yields	(53–70%).	Furthermore,	



















































was	 performed	 on	 Silica	 gel	 60	 F254	 pre-coated	 aluminium	 sheets.	 Flash	 chromatography	 was	




spectra	 were	 obtained	 on	 a	 Bruker	 Esquire3000plus	 spectrometer	 by	 direct	 injection	 in	 positive	
polarity	of	the	ion	trap	detector.	High	resolution	mass	spectra	were	acquired	on	a	Bruker	maXis	4G	

























compounds	 were	 freeze	 dried	 and	 confirmed	 by	 HRMS	 (ESI)	 and	 NMR.	 In	 some	 cases,	 pure	
diastereomers	could	be	separated.	However	epimerization	occurred	very	faster	after	purification.	Due	










































































































































































Rhodamine	 B	 (0.600	 g,	 1.35	mmol),	 2,3,4,5,6-pentafluorophenol	 (0.250	 g,	 1.36	mmol)	 and	 4-(N,N-
dimethylamino)pyridine	(0.021	g,	0.17	mmol)	were	dissolved	in	20	ml	of	dry	DCM	under	nitrogen	and	
N,N’-dicyclohexylcarbodiimide	 (0.327	 g,	 1.59	mmol)	 as	 a	 solution	 in	 2	ml	 of	 DCM	was	 added	with	
continuous	stirring.	The	mixture	was	stirred	at	room	temperature	until	complete	as	judged	by	TLC	(2	
h).	 It	 was	 then	 evaporated	 and	 the	 residue	 purified	 by	 column	 chromatography	 on	 Si60	 in	
DCM/methanol	to	afford	0.46	g	target	product	as	a	dark	purple	solid	(55%).	The	obtained	rhodamine-































































































 final concentration stock solution volume  
protein 107 µM  115 µM  15 µL 
Trypsin 2.1 µM  85 µM  0.4 µL 
CaCl2 4.2 µM  100 µM  0.7 µL 
	
The	trypsin	digestion	reaction	mixture	was	left	at	37	°C	for	3-4	h	and	quenched	by	10%	formic	acid	and	













80%	 and	 33%,	 respectively.	 The	 excess	 of	 free	 dye	 was	 removed	 by	 dialysis.	 DyLight488-labelled	
protein	concentration	was	kept	constant	at	50	nM	for	DgrA	and	100	nM	for	DgrA	W75A,	while	c-di-






















Solid-phase	 oligonucleotide	 synthesis	 was	 carried	 out	 on	 1	 µmol	 CPG	 columns	 using	 standard	
































Methyl	 2-(4-azidophenyl)-2-diazoacetate	 (14	mg,	 0.064	mmol),	 aniline	 (6.57	mg,	 0.071	mmol)	 and	
propargyl	alchol	(3.6	mg,	0.064	mmol)	were	mixed	in	tert-butanol	(1.37	mL)	under	nitrogen,	and	500	
mM	MES	buffer,	pH	6.0	(0.514	mL),	100	mM	CuSO4	in	water	(0.032	mL)	were	then	added,	the	mixture	



















was	 extracted	 with	 3×	 6	 mL	 of	 dichloromethane.	 The	 combined	 organic	 layers	 were	 dried	 with	
















%	 (w/v)	 K2CO3	was	 added,	 and	 the	mixture	was	 extracted	with	 3×	 6	mL	 of	 dichloromethane.	 The	
combined	organic	 layers	were	dried	with	anhydrous	sodium	sulfate,	evaporated	under	vacuum	and	


























of	glucose	outside	of	 the	membrane.	 It	also	helps	glucose	 to	be	broken	down	 into	pyruvate	 in	 the	
glycolysis	pathway	yielding	ATP	(adenosine	triphosphate)	and	NADH	(reduced	nicotinamide	adenine	
dinucleotide).	Later	different	phosphorylated	intermediates	are	involved	in	each	step	of	the	glucolysis	
pathway.	 These	 phospho-metabolites	 are	 also	 very	 important	 substrates,	 starting	 materials	 or	
cofactors	 in	 many	 other	 biological	 pathways	 (Figure	 3.1).	 For	 example,	 the	 intermediate	
dihydroxyacetone	phosphate	(DHAP)	is	the	source	of	the	glycerol	which	can	couple	with	fatty	acids	to	
form	 body	 fat.	 Furthermore,	 G	 6-P	 also	 supplies	 ribulose	 5-phosphate	 in	 the	 pentose	 phosphate	



















Besides	 in	 the	 sugar	 metabolic	 pathway,	 phosphate	 also	 plays	 an	 important	 role	 in	 many	 other	
biomolecules’	biosynthetic	pathways	(See	Figure	3.1).	Choline,	which	serves	as	the	hydrophilic	head	in	
the	 cell	 membrane,	 is	 linked	 to	 fatty	 acids	 via	 a	 phosphate	 ester	 (Figure	 3.2).	 Choline	 and	 its	
metabolites	are	important	nutrients	for	humans,	and	they	play	a	great	role	in	structural	integrity,	cell	
signaling	 and	 cholinergic	 neurotransmission.	 They	 are	 rich	 in	 milk	 and	 egg	 as	 free	 choline,	
























change	 in	 chemical	 properties	 that	 it	 is	 often	 used	 as	 a	 chemical	 signal,	 for	 example	 in	 protein	
68	
	







The	 first	 example	 of	 phosphorylation	was	 discovered	 in	 the	 late	 1930s.	 During	 the	 study	 of	 sugar	
metabolisms,	Carl	and	Gerty	Cori	discovered	G	6-P	as	the	first	intermediate	of	the	glycogen	breakdown	









who	 later	discovered	 that	phosphorylase	b	 could	be	 converted	 to	a	 in	 the	presence	of	Mg-ATP	by	
phosphorylase	kinase.116	They	also	proved	that	prosthetic-group-removing'	(or	PR)	enzyme	is	actually	




5’-AMP	 linked	phosphorylase	 is	 the	active	 form	 in	1930s.	After	 two	decades	of	 strenuous	 trial	 and	





Figure	 3.5	 The	 glycogenolytic	 cascade119:	 Adrenalin	 stimulates	 the	 production	 of	 (c-AMP)	 leading	 to	 the	 sequential	
activation	of	c-AMP-dependent	protein	kinase	and	phosphorylase	kinase.		
PKA	 is	 known	as	 cyclic	AMP-dependent	protein	kinase	which	phosphorylates	phosphorylase	kinase	
(they	called	it	kinase	kinase	when	they	sent	the	draft	to	the	editors).	Their	concept	of	reversible	protein	
phosphorylation	 in	 this	 phosphorylation	 cascade	 is	 embarrassingly	 simple	 according	 to	 their	 own	
humble	comments,	yet	today	this	theory	proves	to	be	an	absolute	crucial	phenomenon	in	every	aspect	















One	 of	 the	 oldest	 and	most	 investigated	 protein	 kinase,	 c-Src,	will	 be	 used	 here	 to	 exemplify	 the	
complexity	of	this	process.121-124	C-Src	(cellular	Src	kinase)	is	a	proto-oncogene	tyrosine-protein	kinase	
which	means	 it	 phosphorylates	 specific	 tyrosine	 residues	 in	 other	 proteins.	 A	 different	 protein	 C-



























metal	 ligands	 in	 the	 IMAC	 technique	 indicates	 the	 state-of-the-art.130	 IMAC’s	 high	 sensitivity	 and	




peptides	 from	 phosphatase-treated	 aliquot	 (blue,	 light	 isotope	 labelled)	 will	 represent	 the	 total	
peptides,	 while	 the	 unphosphorylated	 counterpart	 in	 the	 untreated	 aliquot	 (red,	 heavy	 isotope	




















group	 which	 could	 be	 captured	 by	 iodoacetyl	 groups	 immobilized	 on	 glass	 beads.	 Both	 methods	






The	 phosphate	 group	 and	 its	 esters	 are	 ubiquitous	 in	 nature,	 serving	 critical	 roles	 in	metabolism,	
nucleic	 acids	 and	 cell	membranes.	 Especially	 protein	 phosphorylation	 is	 the	most	 important	 post-
translation	modification	of	proteins,	and	yet,	despite	more	than	sixty	years	of	study,	it	remains	poorly	
understood	 since	 signal	 transduction	 networks	 in	 the	 phosphorylation	 cascade	 are	 complicated	 to	
trace.	Chemical	modification	of	phosphate	biomolecules	is	in	a	urgent	need	due	to	its	important	role	
in	biological	process.	There	are	a	handful	of	cases	of	phosphate	ester	alkylation	by	diazo	compounds	
as	 I	 discussed	 	 in	 Chapter	 1.	 For	 example,	 nucleotide	 monophosphates	 were	 first	 modified	 by	
phenyldiazomethane	 in	 1955.47	 Diazo-substituted	 coumarin	 has	 been	 employed	 to	 react	 with	 the	
phosphate	 moiety	 of	 the	 backbone	 of	 RNA,	 modifying	 approximately	 30	 sites	 on	 the	 phosphate	
moieties	per	1	kb	of	RNA	sequence.52	The	modification	of	seconD	messager	c-AMP	and	c-GMP	with	
diazo	 compounds	has	been	managed	albeit	 in	 low	yield	 (average	10-15%).134	 In	most	of	 the	 cases,	
DMSO	 or	 methanol	 is	 chosen	 rather	 than	 aqueous	 buffer	 for	 phosphate	 esterfication	 with	 diazo	





Many	bioactive	molecules	have	both	 carboxylate	 and	phosphate	 group	 in	presence	of	many	other	





















If	 the	 conjugate	 base	 (3.1	 in	 Figure	 3.9A)	 is	 too	 basic	 it	 will	 be	 protonated	 quickly	 by	 water	 and	




3.9)	 to	 initiate	 reaction	 –	 compounds	 in	 this	 class	 include	 diazomalonates	 and	 donor-acceptor	
substituted	diazo	esters.	These	stable	diazo	compounds	have	long	lifetimes	in	water	and	hence	can	be	
used	to	perform	aqueous	metal-carbene	reactions.	Their	weak	basicity,	however,	renders	them	of	little	
value	 in	 BrØnsted	 acid	 alkylation.	 Quantifying	 the	middle	 ground	 between	 these	 two	 extremes	 is	
75	
	
essential	 for	controlling	selectivity	 in	diazo-type	esterifications.	The	first	step	 in	a	productive	diazo-
type	O-alkylation	 is	protonation	by	the	BrØnsted	acid	(see	Path	B	 in	Figure	3.9A).	 It	should	then	be	
possible	 to	 exploit	 pKa	 differences	 between	 acids	 to	 control	 O-alkylation	 selectivity.	 To	 test	 this	
hypothesis	we	examined	product	 ratios	of	CMP	versus	benzoic	acid	alkylation	 in	aqueous	buffer	at	
different	pHs	using	commercially	available	trimethylsilyldiazomethane	3.1c	as	the	diazo	compound.	
Indeed	at	 low	pH	benzoic	acid	alkylation	 is	preferred,	but	as	 the	pH	 is	 raised	phosphate	alkylation	
begins	to	dominate	(see	Figure	3.9B).	This	is	consistent	with	benzoic	acid	being	largely	benzoate	at	pHs	
higher	 than	 6,	 while	 a	 large	 fraction	 of	 the	 phosphate	 remains	 protonated.	 Although	 3.1c	 was	 a	




acidity	 in	 their	discussion	of	ester	alkylation	 (See	Figure	3.10	 right).	 In	 the	measurement	of	pKa	of	
diazomethane,	McGarrity136	found	the		acidity		of	methanediazonium	ion		in		THF-water		is		similar		to		
that		of		nitromethane		in		water		(pKa	=	10.2).	So	we	could	have	a	better	idea	of	the	acidity	of	diazo	
compounds	 using	 McGarrity’s	 result	 (Figure	 10	 left)	 than	 Raines	 theory.	 In	 this	 manner,	 phenyl	














to	make	 it	more	 stable	 in	water.	 The	modification	 of	 serine	 and	 tyrosine	 phosphate	 only	 give	 the	
phosphate	product	as	we	desired.	But	in	the	case	of	serine	phosphate	(3.6f),	side	product	carboxylic	
esterfication	was	observed	when	diazo	 is	 increase	 to	10	equivalents.	This	 could	be	 	a	 result	of	 the	
proximity	of	the	serine	carboxylate	to	the	formed	tight	ion	pair	intermediate.	In	general	we	consider	




Modifications	 of	 phosphates	 within	 large	 biopolymers	 would	 be	 a	 valuable	 application	 of	 diazo	
alkylation.	 This	 reaction	 has	 previously	 been	 employed	 in	 the	 alkylation	 of	 nucleoside	







phosphate	 diester	 alkylation,	 but	 under	 these	 forcing	 conditions	 substantial	 amounts	 of	 sulfonate	
alkylation	 of	 the	MES	 buffer	 salt	 were	 also	 observed	 (experimental	 part).	 The	 dramatic	 reactivity	
difference	between	mono-	and	diesters	augured	well	for	a	selective	5’-phosphate	alkylation	in	larger	
oligonucleotides.	 Oligonucleotides	 bearing	 terminal	 phosphates	 are	 alkylated	 selectively.	 A	 simple	
hexanucleotide	 (8,	 see	 trace	 a	 in	 Figure	 3.12B)	 bearing	 a	 5’-phosphate	was	 treated	with	 the	diazo	
compound	3.1d	in	varying	amounts	at	pH	7	(see	traces	b-g	in	Figure	3.12B).	Optimal	conversion	was	
observed	at	20	equivalents	of	3.1e	with	further	increases	leading	to	little	improvement.	The	reactions	









Protein	 phosphorylation	 is	 a	 widespread	 post-translational	 modification	 that	 regulates	 numerous	
functions.	The	ability	to	selectively	modify	phosphates	in	a	native	protein	would	be	a	powerful	tool	for	










































1	 3.10	 4	 20	 3.13a	 40	 1:9d	 	
2	 3.10	 7	 2	 3.12	 43	(35)	 13:1	 	
3	 3.10	 7	 3	 3.12	 52	(42)	 15:1	 	
4	 3.10	 7	 5	 3.12	 68(44)	 11:1	 	
5	 3.10	 7	 10	 3.12	 75(47)	 11:1	 	
6	 3.10	 7	 15	 3.1	 95	 11:1	 	
7	 3.11	 7	 10	 3.14	 30	 n.	a.	 	
aRun	in	5mM	MOPS	buffer	at	pH	7,	pH	4	experiment	is	run	in	unbuffered	water	and	the	pH	is	measured	after	the	














1	 3.15	 7	 3	 3.17	 43	(43)	 99:1	
2	 3.15	 7	 10	 3.17	 70	(56)	 5:1	
3	 3.15	 7	 100	 3.17	 81	(56)	 3:1	
4	 3.16	 7	 20	 3.16	 0	 	





























acids,	 and	 phosphate	 bearing	metabolites.	 Perhaps	 the	most	 exciting	 future	 application,	 however,	
would	 be	 in	 global	 phosphoproteomics,	 an	 area	 that	 suffers	 from	 a	 lack	 of	 selective	 pull-down	













All	 chemicals	 were	 purchased	 from	 Sigma-Aldrich	 or	 TCI	 and	 used	 as	 received.	 Peptides	 were	
purchased	 from	 Bachem,	 oligonucleotides	 from	Microsynth	 and	 used	 as	 received	 without	 further	
purification.	1H	and	13C	NMR	were	acquired	on	a	Bruker	400	MHz,	500	MHz	or	AvanceIII+	600	MHz	







C18	 110	 Å,	 LC	 Column	 250	 x	 21.2	 mm,	 AXIA™	 Packed)	 was	 employed	 for	 purification.	 100	 mM	
triethylammonium	acetate	 (pH	7.2-7.3)	and	acetonitrile	were	used	as	mobile	phases.	Flow	rate:	20	
















We	 tested	 two	 oxidation	 methods:	 Swern	 Oxidation	 and	 MnO2	 oxidation.	 They	 both	 work	 well.	




decomposition	afterwards,	especially	 for	benzyl	diazo	which	 is	very	unstable	at	 room	temperature.	
Once	formed,	benzyl	diazo	is	used	for	modification	reactions	directly	after	work	up	and	without	further	







































































































































































































































48	mg	 of	 glucose	monophosphate	 dipotassium	 salt	 was	 dissolved	 in	 2.85	mL	 of	MES	 buffer	 pH	 6	
followed	by	the	addition	of	233	mg	of	2-nitro-phenyl	diazomethane.	The	reaction	proceeded	smoothly	
and	the	aqueous	solution	was	purified	by	preparative	HPLC.	The	desired	product	eluted	at	17	min.	The	
product	 fractions	were	 combined	 and	 lyophilized	 to	 afford	 the	desired	product	 (42	mg,	 74%).	 The	








































found	 that	 phosphodiesters	 remained	 unconverted	 employing	 10	 equiv.	 of	 diazo	 substrate,	 low	
conversion	 with	 30	 equiv.	 diazo.	 The	 5’-phosphorylated	 hexanucleotide	 is	 alkylated	 with	 high	




	 Reaction	concentration	 10	equiv.	diazo	 30	equiv.	diazo	
c-AMP	 50	mM	 0	 5%	
c-di-GMP	 50	mM	 0	 12%	
TACTGC	 100	µM	 0	 0	









heterogeneous.	 Although	 the	 reagent	 couldn’t	 interact	with	 all	 the	 c-AMP	 solution,	 gas	 formation	
stopped	after	2	h.	The	aqueous	solution	was	transfer	to	a	new	flask	and	washed	with	diethyl	ether	(2	



























equivalents	 of	 diazo.	 Further	 increase	 of	 the	 stoichiometry	 didn’t	 have	 a	 positive	 effect	 on	 the	
conversion.	The	modification	of	5’-phospharylated	oligomer	pTACTGC	at	50	µM	was	also	tested	with	








The	pTACTGC	modification	 showed	mainly	mono-alkylation	product	 and	a	 small	 fraction	of	double	
























0.10	 	 1	 0.10	 30	 01.0	 1	 03.1	
	 0.10	 1	 0.10	 30	 01.0	 	 00.0	
0.10	 	 1	 0.50	 30	 05.0	 5	 26.9	
0.05	 	 1	 0.25	 30	 02.5	 	 19.3	
	 0.10	 1	 0.50	 30	 05.0	 	 0.0	
0.10	 	 1	 1.00	 30	 10.0	 10	 42.3	
0.05	 	 1	 0.50	 30	 05.0	 	 38.1	
	 0.10	 1	 1.00	 30	 10.0	 	 00.0	
0.10	 	 1	 1.50	 30	 15.0	 15	 49.5	
0.05	 	 1	 0.75	 30	 07.5	 	 49.6	
	 0.10	 1	 1.50	 30	 15.0	 	 00.0	
0.10	 	 1	 2.00	 30	 20.0	 20	 56.3	
0.05	 	 1	 1.00	 30	 10.0	 	 54.3	
	 0.10	 1	 2.00	 30	 20.0	 	 00.0	
0.10	 	 1	 2.50	 30	 25.0	 25	 49.2	
0.05	 	 1	 1.25	 30	 12.5	 	 60.0	
	 0.10	 1	 2.50	 30	 25.0	 	 00.0	
0.10	 	 1	 3.00	 30	 30.0	 30	 52.7	
0.05	 	 1	 1.50	 30	 10.0	 	 52.7	
	 0.10	 1	 3.00	 30	 30.0	 	 00.0	
0.10	 	 1	 4.00	 30	 40.0	 40	 47.6	









































to	UPLC-MS	 to	 confirm	 the	 identity	 of	 the	 purified	 peak.	 Sequencing	 of	 the	modified	 peptide	was	

















































1	 1	 19%	 23%	
2	 2	 35%	 43%	
3	 3	 42%	 52%	
4	 4	 47%	 73%	
5	 5	 44%	 68%	
6	 10	 47%	 75%	


















1	 10	 4.3	 20	 13	 40	 1:9d	 	
2	 10	 7	 2	 12	 43(35)	 13:1	 	
3	 10	 7	 3	 12	 52(42)	 15:1	 	
4	 10	 7	 5	 12	 68(44)	 11:1	 	
5	 10	 7	 10	 12	 75(47)	 11:1	 	
6	 10	 7	 15	 12	 95(40)	 11:1	 	
7	 11	 7	 10	 14	 30	 n.d.	 	
aRun	in	5	mM	MOPS	buffer	at	pH	7,	pH	4	experiment	is	run	in	unbuffered	water	and	the	pH	is	
measured	 after	 the	 reaction;	 bfirst	 number	 is	 conversion	 of	 starting	 peptide;	 number	 in	














































































ion	 slice	 m/z	 z	 sequence	
M	 [1-13]	 1678.663	 1	 .TSTEPQYQPGENL.	[1x	NO2-Benzyl	phosphate]	
b2	 [1-2]	 189.087	 1	 .TS.t	 	 	 	
b3	 [1-3]	 290.1347	 1	 .TST.e	 	 	 	
b4	 [1-4]	 419.1773	 1	 .TSTE.p	 	 	 	
b5	 [1-5]	 516.23	 1	 .TSTEP.q	 	 	 	
b6	 [1-6]	 644.2886	 1	 .TSTEPQ.y	 	 	
b7	 [1-7]	 1022.35	 1	 .TSTEPQY.q	[1x	NO2-Benzyl	phosphate]	
b8	 [1-8]	 1150.409	 1	 .TSTEPQYQ.p	[1x	NO2-Benzyl	phosphate]	
b9	 [1-9]	 1247.462	 1	 .TSTEPQYQP.g	[1x	NO2-Benzyl	phosphate]	
b10	 [1-10]	 1304.483	 1	 .TSTEPQYQPG.e	[1x	NO2-Benzyl	phosphate]	
b11	 [1-11]	 1433.526	 1	 .TSTEPQYQPGE.n	[1x	NO2-Benzyl	phosphate]	
b12	 [1-12]	 1547.569	 1	 .TSTEPQYQPGEN.l	[1x	NO2-Benzyl	phosphate]	
y12	 [2-13]	 1577.616	 1	 t.STEPQYQPGENL.	[1x	NO2-Benzyl	phosphate]	
y11	 [3-13]	 1490.584	 1	 s.TEPQYQPGENL.	[1x	NO2-Benzyl	phosphate]	
y10	 [4-13]	 1389.536	 1	 t.EPQYQPGENL.	[1x	NO2-Benzyl	phosphate]	
y9	 [5-13]	 1260.493	 1	 e.PQYQPGENL.	[1x	NO2-Benzyl	phosphate]	
y8	 [6-13]	 1163.441	 1	 p.QYQPGENL.	[1x	NO2-Benzyl	phosphate]	
y7	 [7-13]	 1035.382	 1	 q.YQPGENL.	[1x	NO2-Benzyl	phosphate]	
y6	 [8-13]	 657.3202	 1	 y.QPGENL.	 	 	
y5	 [9-13]	 529.2617	 1	 q.PGENL	 	 	 	
y4	 [10-13]	 432.2089	 1	 p.GENL.	 	 	 	
y3	 [11-13]	 375.1874	 1	 g.ENL.	 	 	 	
y2	 [12-13]	 246.1448	 1	 e.NL.	 	 	 	






ion	 slice	 m/z	 z	 sequence	
M	 [1-13]	 1678.663	 1	 .TSTEPQYQPGENL.	[1xPhosphate;	1x	NO2-benzyl]	
b2	 [1-2]	 189.087	 1	 .TS.t	 	 	 	 	
b3	 [1-3]	 290.1347	 1	 .TST.e	 	 	 	 	
b4	 [1-4]	 419.1773	 1	 .TSTE.p	 	 	 	 	
b5	 [1-5]	 516.23	 1	 .TSTEP.q	 	 	 	 	
b6	 [1-6]	 644.2886	 1	 .TSTEPQ.y	 	 	 	
b7	 [1-7]	 887.3183	 1	 .TSTEPQY.q	[1xPhosphate]	 	 	
b8	 [1-8]	 1015.377	 1	 .TSTEPQYQ.p	[1xPhosphate]	 	 	
b9	 [1-9]	 1112.43	 1	 .TSTEPQYQP.g	[1xPhosphate]	
b10	 [1-10]	 1169.451	 1	 .TSTEPQYQPG.e	[1xPhosphate]	
b11	 [1-11]	 1433.526	 1	 .TSTEPQYQPGE.n	[1xPhosphate;	1x	NO2-benzyl]	
b12	 [1-12]	 1547.569	 1	 .TSTEPQYQPGEN.l	[1xPhosphate;	1x	NO2-benzyl]	
y12	 [2-13]	 1577.616	 1	 t.STEPQYQPGENL.	[1xPhosphate;	1x	NO2-benzyl]	
y11	 [3-13]	 1490.584	 1	 s.TEPQYQPGENL.	[1xPhosphate;	1x	NO2-benzyl]	
y10	 [4-13]	 1389.536	 1	 t.EPQYQPGENL.	[1xPhosphate;	1x	NO2-benzyl]	
y9	 [5-13]	 1260.493	 1	 e.PQYQPGENL.	[1xPhosphate;	1x	NO2-benzyl]	
y8	 [6-13]	 1163.441	 1	 p.QYQPGENL.	[1xPhosphate;	1x	NO2-benzyl]	
y7	 [7-13]	 1035.382	 1	 q.YQPGENL.	[1xPhosphate;	1xNO2-benzyl]	
y6	 [8-13]	 792.3523	 1	 y.QPGENL.	[1x	NO2-benzyl]	 	 	
y5	 [9-13]	 664.2937	 1	 q.PGENL.	[1x	NO2-benzyl]	 	 	
y4	 [10-13]	 567.2409	 1	 p.GENL.	[1x	NO2-benzyl]	 	 	
y3	 [11-13]	 510.2195	 1	 g.ENL.	[1x	NO2-benzyl]	 	 	
y2	 [12-13]	 246.1448	 1	 e.NL.	 	 	 	 	






ion	 slice	 m/z	 z	 sequence	
M	 [1-13]	 1813.695	 1	 .TSTEPQYQPGENL.	[1xBenzyl	phosphate;	1x	NO2-benzyl]	
b2	 [1-2]	 189.087	 1	 .TS.t	 	 	 	 	 	
b3	 [1-3]	 290.1347	 1	 .TST.e	 	 	 	 	 	
b4	 [1-4]	 419.1773	 1	 .TSTE.p	 	 	 	 	 	
b5	 [1-5]	 516.23	 1	 .TSTEP.q	 	 	 	 	 	
b6	 [1-6]	 644.2886	 1	 .TSTEPQ.y	 	 	 	 	
b7	 [1-7]	 1022.35	 1	 .TSTEPQY.q	[1x	NO2-Benzyl	phosphate]	 	 	
b8	 [1-8]	 1150.409	 1	 .TSTEPQYQ.p	[1x	NO2-Benzyl	phosphate]	
b9	 [1-9]	 1247.462	 1	 .TSTEPQYQP.g	[1x	NO2-Benzyl	phosphate]	
b10	 [1-10]	 1304.483	 1	 .TSTEPQYQPG.e	[1x	NO2-Benzyl	phosphate]	
b11	 [1-11]	 1568.558	 1	 .TSTEPQYQPGE.n	[1x	NO2-Benzyl	phosphate;	1xNO2-benzyl]	
b12	 [1-12]	 1682.601	 1	 .TSTEPQYQPGEN.l	[1x	NO2-Benzyl	phosphate;1xNO2benzyl]	
y12	 [2-13]	 1712.648	 1	 t.STEPQYQPGENL.	[1x	NO2-Benzyl	phosphate;1xNO2-benzyl]	
y11	 [3-13]	 1625.616	 1	 s.TEPQYQPGENL.	[1x	NO2-Benzyl	phosphate;	1x	NO2-benzyl]	
y10	 [4-13]	 1524.568	 1	 t.EPQYQPGENL.	[1x	NO2-Benzyl	phosphate;	1x	NO2-benzyl]	
y9	 [5-13]	 1395.525	 1	 e.PQYQPGENL.	[1x	NO2-Benzyl	phosphate;	1x	NO2--benzyl]	
y8	 [6-13]	 1298.473	 1	 p.QYQPGENL.	[1x	NO2-Benzyl	phosphate;	1x	NO2-benzyl]	
y7	 [7-13]	 1170.414	 1	 q.YQPGENL.	[1x	NO2-Benzyl	phosphate;	1x	NO2-benzyl]	
y6	 [8-13]	 792.3523	 1	 y.QPGENL.	[1x	NO2-benzyl]	 	 	 	
y5	 [9-13]	 664.2937	 1	 q.PGENL.	[1x	NO2-benzyl]	 	 	 	
y4	 [10-13]	 567.2409	 1	 p.GENL.	[1x	NO2-benzyl]	 	 	 	
y3	 [11-13]	 510.2195	 1	 g.ENL.	[1x	NO2-benzyl]	 	 	 	
y2	 [12-13]	 246.1448	 1	 e.NL.	 	 	 	 	 	























































5mer	 peptide	was	 obtained	 from	Bachem	as	 ammonium	 salt	 and	was	 dissolved	 in	DMSO	as	 stock	
solution	due	 its	 low	solubility	 in	water.	The	modification	with	different	equiv.	of	diazo	reagent	was	











ion	 slice	 m/z	 z	 sequence	
b2	 [1-2]	 534.1636	 1	 .IY.g	[1xAcetyl;	1xNO2-Benzyl	phosphate]	
b3	 [1-3]	 591.1851	 1	 .IYG.e	[1xAcetyl;	1xNO2-Benzyl	phosphate]	
b4	 [1-4]	 720.2276	 1	 .IYGE.f	[1xAcetyl;	1xNO2-Benzyl	phosphate]	
y4	 [2-5]	 729.228	 1	 i.YGEF.	[1xAmide;	1xNO2-Benzyl	phosphate]	
z4	 [2-5]	 712.2014	 1	 i.YGEF.	[1xAmide;	1xNO2-Benzyl	phosphate]	
y3	 [3-5]	 351.1663	 1	 y.GEF.	[1xAmide]	 	 	
z3	 [3-5]	 334.1397	 1	 y.GEF.	[1xAmide]	 	 	
y2	 [4-5]	 294.1448	 1	 g.EF.	[1xAmide]	 	 	
z2	 [4-5]	 277.1183	 1	 g.EF.	[1xAmide]	 	 	
y1	 [5-5]	 165.1022	 1	 e.F.	[1xAmide]	 	 	
























ion	 slice	 m/z	 z	 sequence	 	 	
b2	 [1-2]	 534.1636	 1	 .IY.g	[1xAcetyl;	1xNO2-Benzyl	phosphate]	 	 	
b3	 [1-3]	 591.1851	 1	 .IYG.e	[1xAcetyl;	1xNO2-Benzyl	phosphate]	 	 	
b4	 [1-4]	 855.2597	 1	 .IYGE.f	[1xAcetyl;	1xNO2-Benzyl	phosphate;	1xNO2-benzyl]	
y4	 [2-5]	 864.26	 1	 i.YGEF.	[1xAmide;	1xNO2-Benzyl	phosphate;	1xNO2-benzyl]	
z4	 [2-5]	 847.2335	 1	 i.YGEF.	[1xAmide;	1xNO2-Benzyl	phosphate;	1xNO2-benzyl]	
y3	 [3-5]	 486.1983	 1	 y.GEF.	[1xAmide;	1xNO2-benzyl]	 	 	
z3	 [3-5]	 469.1718	 1	 y.GEF.	[1xAmide;	1xNO2--benzyl]	 	 	
y2	 [4-5]	 429.1769	 1	 g.EF.	[1xAmide;	1xNO2-benzyl]	 	 	 	
z2	 [4-5]	 412.1503	 1	 g.EF.	[1xAmide;	1xNO2-benzyl]	 	 	 	
y1	 [5-5]	 165.1022	 1	 e.F.	[1xAmide]	 	 	 	 	



























(Figure	 4.1,	 upper).	 Euchromatin,	 the	 lightly	 packed	 form	 of	 chromatin,	 usually	 has	 low	 DNA	
methylation	levels	and	less	condensed.	It	contains	most	actively	transcribed	genes	and	promotes	the	















understood,	 the	similar	chemical	modification	of	RNA	starts	 to	gain	 increased	appreciation	 in	gene	
regulation	 only	 recently.	 But	 different	 than	 m5C	 in	 DNA,	 N6-Methyladenosine	 (m6A)	 is	 the	 most	
abundant	modification	 in	RNA.150	 	Even	though	this	methylation	was	 first	 found	 in	virus	 in	1974,151		
later	 it	 was	 detected	 in	 all	 higher	 eukaryotes,	 and	 is	 present	∼3	 times	 per	 mRNA	 on	 average	 in	
mammalian	cells.152,	153	The	biological	function	of	m6A	remained	elusive	for	decades.	Only	very	recently	
a	major	 breakthrough	of	 discovering	 the	 first	m6A	RNA	demethylase	 FTO,	which	 is	 a	 fat	mass	 and	




populations	 demonstrated	 that	 FTO	 variant	 alleles	 (homozygous	 =	 AA	 and	 heterozygous	 =	 AT)	 are	
predisposed	to	greater	adiposity	than	are	those	with	2	wild-type	alleles	(TT).156-159	Carriers	of	one	copy	
of	the	allele	(AT)	weighed	on	average	1.2	kilograms	more	than	people	with	no	copies	(TT).	The	16%	of	








FTO	 protein	 showed	 the	 preference	 of	 binding	 ssRNA	 and	 ssDNA	 over	 dsDNA,	 indicating	 the	
demethylation	target	might	be	RNA	under	physiological	conditions.	It	was	not	until	2011	that	the	FTO	
protein	was	characterized	as	a	m6A	demethylase	in	RNA	expression	regulation.154	But	the	regulatory	























The	 recent	 advances164,165	 in	 sequencing	 of	 methylation	 at	 single-base	 resolution	 provide	 a	
comprehensive	view	of	genomic	methylation	patterns,	and	should	promote	progress	in	understanding	






substrates,	 AlkB	 oxidizes	 the	 carbon	 attached	 to	 a	 nucleobase	 nitrogen	 atom	 (i.e.	 ring	 nitrogen	or	
exocyclic	amine).	The	ten-eleven	translocation	(TET)	proteins	are	AlkB	family	like	DNA	demethylases	




O6	 position	 of	 the	 guanosine.	 The	 various	 demethylases	 show	 different	 substrate	 recognition	
specificity	 through	 several	 demethylation	 mechanisms	 (Figure	 4.3).	 They	 also	 indicate	 that	 the	

























studies	 suggested	 that	m6A	may	pose	an	 important	mark	 for	 recruiting	components	of	 the	splicing	
machinery	and	the	FTO	protein	increases	the	rate	of	splicing	by	regulating	the	RNA	binding	ability.179	
Understanding	of	the	link	between	FTO	and	energy	homeostasis	by	unraveling	mechanisms	of	splicing	































through	 formation	of	 the	O6-[(2,4,6-triisopropylphenyl)sulfonyl]	 ester.	A	major	 side	product	 of	 this	








After	 several	months’	 struggle,	we	 could	 obtain	 0.6	 gram	of	 the	 finally	 product	 and	 0.3	 gram	was	
incorporated	into	the	solid-phase	synthesizer	for	the	15mer-RNA	synthesis	with	the	sequence	of	5ʹ-














After	 lysis	of	 the	cell	pellets,	 the	 filtered	supernatant	was	purified	by	Ni-NTA	chromatography.	The	
















valuable	 for	our	 later	 research.	Commercial	 available	 convertible	RNA	phosphoramidite	 could	be	a	
better	solution	in	this	case	which	can	help	us	push	the	project	further	and	faster.	Cooperation	with	
biologists	might	help	chemists	to	solve	the	mammalian	protein	production	in	bacteria.		








exo-amine	 modified	 oligonucleotides	 are	 tolerated	 by	 the	 FTO	 protein,	 AlkB	 protein,	 and	 other	














was	 performed	 on	 Silica	 gel	 60	 F254	 pre-coated	 aluminium	 sheets.	 Flash	 chromatography	 was	




spectra	 were	 obtained	 on	 a	 Bruker	 Esquire3000plus	 spectrometer	 by	 direct	 injection	 in	 positive	
polarity	of	the	ion	trap	detector.	High	resolution	mass	spectra	were	acquired	on	a	Bruker	maXis	4G	















is	 the	 convertible	 monomer.	 The	 standard	 1	 µmol	 RNA	 synthesis	 cycle	 was	 modified	 to	 have	 an	
extended	 coupling	 time	 of	 12	 min.	 All	 phosphoramidites,	 including	 the	 convertible	 nucleoside	
phosphoramidites	were	dissolved	to	a	concentration	of	0.1	M	in	anhydrous	CH3CN.		However	during	





The	 resin-bound	 oligonucleotide	 was	 first	 cleavaged	 from	 the	 resin	 with	 1.5	 mL	 of	 ethanolic	
methylamine	solution	(8	M)	for	2	hours,	then	heated	at	42	°	C	for	18	hours.	The	resulting	solution	was	
concentrated	 under	 vacuum.	 Removal	 of	 the	 2ʹ-O-silyl	 ether	 was	 afforded	 by	 treating	 the	
oligonucleotide	with	0.6	mL	of	1	M	tetrabutylammonium	fluoride	(TBAF)	in	THF	for	20	hours	at	room	







































nitrogen,	and	 stored	at	 -80	 °C.	All	 subsequent	 steps	were	performed	at	4	 °C.	The	cell	pellets	were	
resuspended	in	buffer	A	(50mM	imidazole,	300mM	NaCl,	50mM	sodium	phosphate,	pH	8.0),	sonicated	
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